Will Canopy Growth (TSX:WEED) Stock Rebound in 2020?

Canopy Growth Corp. (TSX:WEED)(NYSE:CGC) stock could rebound stronger than before in 2020.

| More on:

The first full year of legalization was surprisingly rough for marijuana stocks across the board. The industry has collectively lost $21 billion (or roughly a third) of its combined market capitalization in 2019 alone. High-profile executives like Cam Battley and Bruce Linton lost their jobs while high-profile institutional investors were humbled by their performance in this sector. 

However, this is a new year and there are signs that the cannabis sector could rebound stronger than before in 2020. In particular, the fallout from last year could help industry leaders like Canopy Growth Corp. (TSX:WEED)(NYSE:CGC) consolidate their position. 

Here are three reasons I believe Canopy’s stock could regain its peak valuation in the year ahead. 

Cash reserves

At the time of writing, Canopy has nearly $2.75 billion in cash and cash equivalents on its books. That’s plenty of money to keep production going as the distribution channels settle. 

In fact, the company can now use its cash hoard to acquire smaller players that have suffered from last year’s market shakeout. Smaller firms that have invested heavily in their production facilities and are now dealing with unsustainable debt could be acquired and consolidated by the cash-rich, low-debt market leader. 

A market consolidation will further cement Canopy’s position in this sector. 

Cannabis 2.0 launches

Investors should expect edible cannabis products to have a larger pool of buyers and command higher margins. There are a lot more people willing to ingest cannabis products rather than smoke or inhale it. It’s also easier to brand and market these items as recreational products for the average consumer. 

With 13 cannabis-infused drinks and a line of cannabis-infused chocolate as part of its Cannabis 2.0. portfolio and a joint venture with Toronto rap star Drake, Canopy is already well ahead of the rest in this market. If the products have the desired impact on the company’s margins, Canopy’s timeline for profitability could be shortened considerably.

New management

A change in the C-suite is a critical catalyst for most companies. David Klein, the chief financial officer at Canopy’s largest shareholder Constellation Brands, is expected to take over the chief executive officer role from Mark Zekulin, effective this week. 

Considering the fact that Klein is a former financial executive, investors should expect the company’s focus to shift to the bottom line going forward. A shift in strategy and a focus on financial efficiency is exactly what this company needs to unlock value.

Canopy’s stock currently trades at just 1.86 times book value and 3.27 times cash per share. Considering the immense potential for global cannabis sales and Canopy’s dominant position in the market, I expect Canopy’s stock to surge back up to reflect its capacity for growth.

Bottom line

The fallout from last year could benefit industry leaders like Canopy Growth in 2020. Profitability is the firm’s main issue at the moment, but with higher-margin products being rolled out this year and decreased competition from failed rivals, this issue could be resolved. Canopy has all the resources and market share it needs to rebound stronger than before and dominate the market in the new year.

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

The Motley Fool recommends Constellation Brands. Fool contributor Vishesh Raisinghani has no position in any of the stocks mentioned.

More on Cannabis Stocks

Cannabis business and marijuana industry concept as the shadow of a dollar sign on a group of leaves
Cannabis Stocks

Could the Cannabis Bubble Re-Inflate?

Let's dive into the question of whether the Canadian cannabis bubble can re-inflate from here.

Read more »

Cannabis business and marijuana industry concept as the shadow of a dollar sign on a group of leaves
Cannabis Stocks

Should You Buy Canopy Growth Stock or Green Thumb Stock Today?

Let's dive into two cannabis giants, and which one may be the better pick for long-term investors.

Read more »

Farmer smiles near cannabis crop
Cannabis Stocks

Could Aurora Cannabis Stock Finally Recover by Year-End?

Down 99% from all-time highs, Aurora Cannabis stock is focused on improving profit margins and expanding sales of its medical…

Read more »

Farmer smiles near cannabis crop
Cannabis Stocks

Are Pot Stocks About to Surge Again? 

With pot stocks making big moves of late, many investors are now asking whether the cannabis sector is worth investing…

Read more »

Farmer smiles near cannabis crop
Cannabis Stocks

Can Pot Stocks Aurora Cannabis and Canopy Growth Bounce Back in Q4?

Down over 99% from all-time highs, Canadian pot stocks such as Aurora Cannabis and Canopy Growth remain high-risk bets.

Read more »

Worker tags plants at an industrial cannabis operation
Cannabis Stocks

Can Canopy Growth Stock Finally Recover in 2024?

Down 98% from all-time highs, Canopy Growth remains a high-risk investment in 2024 given its weak fundamentals.

Read more »

Tech Stocks

3 No-Brainer Stocks to Buy With $20 Right Now

These three stocks are easy buys for those who don't have all that much to spend, and want long-term growth…

Read more »

Pot stocks are a riskier investment
Cannabis Stocks

Slow Burn: Is Aurora Cannabis Finally a Good Buy in June?

One of the benefits of choosing from some of the most beaten-down market segments like cannabis is that even a…

Read more »